US$ 22.61
latest news on glp 1 drugs Risks of Ozempic, other GLP-1 are at center of sweeping lawsuit that kicked off in Philadelphia Study flags need to monitor
Description
MASH typically develops in individuals with obesity, insulin resistance, and metabolic syndrome

2022 Sep;63:101533

GLP-1 and GCG are products of the proglucagon gene, arising from tissue-specific post-translational processing, and share a large degree of sequence homology
Protecting that investment with appropriate treatment duration planning makes the extended course worthwhile for most patients

The same research also reported reduced adhesion molecules and lower carotid intimamedia thickness, suggesting improved vascular regulation

Abstract 54-OR
